Thomas Melchardt

2.4k total citations
93 papers, 1.4k citations indexed

About

Thomas Melchardt is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Melchardt has authored 93 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 45 papers in Genetics and 35 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Melchardt's work include Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers). Thomas Melchardt is often cited by papers focused on Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers). Thomas Melchardt collaborates with scholars based in Austria, Germany and United States. Thomas Melchardt's co-authors include Richard Greil, Alexander Egle, Lukas Weiß, Daniel Neureiter, Teresa Magnes, Gabriel Rinnerthaler, Clemens Hufnagl, Florian Huemer, Peter Neumeister and Konstantin Schlick and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Thomas Melchardt

88 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Melchardt Austria 23 559 486 396 380 247 93 1.4k
Stefan Dirnhofer Switzerland 22 539 1.0× 324 0.7× 548 1.4× 367 1.0× 196 0.8× 89 1.6k
Joanne Lager United States 17 439 0.8× 389 0.8× 215 0.5× 563 1.5× 296 1.2× 37 1.2k
Raja Luthra United States 24 526 0.9× 439 0.9× 367 0.9× 456 1.2× 607 2.5× 54 1.7k
José María Sayagués Spain 23 292 0.5× 231 0.5× 249 0.6× 367 1.0× 294 1.2× 66 1.3k
B. Audhuy France 20 986 1.8× 375 0.8× 492 1.2× 437 1.1× 432 1.7× 48 1.9k
Nicola Di Renzo Italy 24 681 1.2× 631 1.3× 944 2.4× 329 0.9× 531 2.1× 98 1.9k
Dehui Zou China 20 666 1.2× 364 0.7× 417 1.1× 519 1.4× 554 2.2× 162 1.4k
J. Rifón Spain 18 316 0.6× 361 0.7× 253 0.6× 641 1.7× 515 2.1× 60 1.5k
Ellen D. McPhail United States 23 508 0.9× 558 1.1× 798 2.0× 724 1.9× 98 0.4× 110 1.7k
Miguel Alcoceba Spain 21 442 0.8× 460 0.9× 439 1.1× 322 0.8× 362 1.5× 79 1.3k

Countries citing papers authored by Thomas Melchardt

Since Specialization
Citations

This map shows the geographic impact of Thomas Melchardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Melchardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Melchardt more than expected).

Fields of papers citing papers by Thomas Melchardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Melchardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Melchardt. The network helps show where Thomas Melchardt may publish in the future.

Co-authorship network of co-authors of Thomas Melchardt

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Melchardt. A scholar is included among the top collaborators of Thomas Melchardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Melchardt. Thomas Melchardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rendl, Gundula, Jan Marco Kern, Lenka Bašková, et al.. (2025). Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei. Haematologica. 111(3). 1120–1124.
2.
Wulf, Gerald, Ulrike Bacher, Mathias Rummel, et al.. (2024). Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe. Cancer Medicine. 13(10). e7289–e7289. 1 indexed citations
3.
Leisch, Michael, Franz Josef Gassner, Nadja Zaborsky, et al.. (2023). Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. Cancers. 15(8). 2305–2305. 12 indexed citations
4.
Melchardt, Thomas, Alexander Egle, & Richard Greil. (2023). How I treat diffuse large B-cell lymphoma. ESMO Open. 8(1). 100750–100750. 25 indexed citations
5.
Huemer, Florian, Stefan Hecht, Gabriel Rinnerthaler, et al.. (2022). Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol. Journal of Cancer Research and Clinical Oncology. 149(7). 3051–3064. 7 indexed citations
6.
Magnes, Teresa, Aaron R. Thorner, Daniel Neureiter, et al.. (2021). Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence. ESMO Open. 6(1). 100012–100012. 10 indexed citations
7.
Hatzl, Stefan, Florian Posch, Christine Beham‐Schmid, et al.. (2021). Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy. Supportive Care in Cancer. 29(9). 5197–5207. 6 indexed citations
8.
Magnes, Teresa, Thomas Melchardt, Lukas Weiß, et al.. (2021). Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone. Wiener klinische Wochenschrift. 133(21-22). 1131–1136. 5 indexed citations
9.
Schlick, Konstantin, Florian Huemer, Nadja Zaborsky, et al.. (2021). Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer. Pancreatology. 21(8). 1466–1471. 9 indexed citations
10.
11.
Melchardt, Thomas, et al.. (2020). Ropeginterferon alfa-2b for the treatment of patients withpolycythemia vera. Drugs of today. 56(3). 195–195. 12 indexed citations
12.
Burgstaller, Sonja, Veronika Buxhofer‐Ausch, Thamer Sliwa, et al.. (2018). Austrian recommendations for the management of polycythemia vera. Wiener klinische Wochenschrift. 130(17-18). 535–542. 3 indexed citations
13.
Magnes, Teresa, Thomas Melchardt, Clemens Hufnagl, et al.. (2017). The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab. The Pharmacogenomics Journal. 18(3). 474–479. 18 indexed citations
14.
Melchardt, Thomas, Katharina Troppan, Lukas Weiß, et al.. (2015). Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI. Journal of the National Comprehensive Cancer Network. 13(12). 1501–1508. 25 indexed citations
15.
Mian, Michael, Gabriele Gamerith, Patrizia Mondello, et al.. (2014). R-CHOP versus R-COMP: Are They Really Equally Effective?. Clinical Oncology. 26(10). 648–652. 11 indexed citations
16.
Berghoff, Anna S., Thomas Melchardt, Rupert Bartsch, et al.. (2014). αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. Clinical & Experimental Metastasis. 31(7). 841–851. 60 indexed citations
17.
Melchardt, Thomas, Lukas Weiß, Lisa Pleyer, et al.. (2013). Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome. Oncology Letters. 6(6). 1756–1758. 1 indexed citations
18.
Melchardt, Thomas, Stefan Habringer, Clemens Hufnagl, et al.. (2013). Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Annals of Oncology. 25(1). 171–176. 48 indexed citations
19.
Melchardt, Thomas, Lukas Weiß, Richard Greil, & Alexander Egle. (2012). Viral infections and their management in patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 54(8). 1602–1613. 27 indexed citations
20.
Melchardt, Thomas, et al.. (2010). An uncommon cause of anaemia: Sheehan's syndrome. Wiener klinische Wochenschrift. 122(23-24). 717–719. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Dirnhofer Breakdown of academic impact, for papers by Joanne Lager Breakdown of academic impact, for papers by Raja Luthra Breakdown of academic impact, for papers by José María Sayagués Breakdown of academic impact, for papers by B. Audhuy Breakdown of academic impact, for papers by Nicola Di Renzo Breakdown of academic impact, for papers by Dehui Zou Breakdown of academic impact, for papers by J. Rifón Breakdown of academic impact, for papers by Ellen D. McPhail Breakdown of academic impact, for papers by Miguel Alcoceba
Rankless by CCL
2026